Quanterix (QTRX) Share-based Compensation (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.56% |
| Dec 31, 2025 | -19.27% |
| Sep 30, 2025 | 1.81% |
| Jun 30, 2025 | -1.65% |
| Mar 31, 2025 | 12.92% |
| Dec 31, 2024 | 3.87% |
| Sep 30, 2024 | -10.92% |
| Jun 30, 2024 | -0.70% |
| Mar 31, 2024 | 21.71% |
| Dec 31, 2023 | -0.39% |
| Sep 30, 2023 | 3.58% |
| Jun 30, 2023 | 6.34% |
| Mar 31, 2023 | 7.67% |
| Dec 31, 2022 | 32.39% |
| Sep 30, 2022 | -46.66% |
| Jun 30, 2022 | 36.40% |
| Mar 31, 2022 | -22.90% |
| Dec 31, 2021 | 23.03% |
| Sep 30, 2021 | 9.81% |
| Jun 30, 2021 | 7.80% |
| Mar 31, 2021 | 8.21% |
| Dec 31, 2020 | 32.58% |
| Sep 30, 2020 | -5.64% |
| Jun 30, 2020 | 18.59% |
| Mar 31, 2020 | 25.91% |
| Dec 31, 2019 | -8.37% |
| Sep 30, 2019 | 14.18% |
| Jun 30, 2019 | 24.69% |
| Mar 31, 2019 | -13.88% |
| Dec 31, 2018 | -20.14% |
| Sep 30, 2018 | 109.78% |
| Jun 30, 2018 | 39.94% |
| Mar 31, 2018 | -13.70% |
| Dec 31, 2017 | 18.30% |
| Sep 30, 2017 | 13.27% |
| Jun 30, 2017 | 113.18% |